TORONTO, April 25, 2025 (GLOBE NEWSWIRE) -- CPOINT Capital Corp. (“CPOINT”) announces that, on April 23, 2025, it and its affiliate Juno Pharmaceuticals LP (“Juno”) acquired 1,875,000 common shares ...
Prior to this acquisition and as reported in the last early warning report of CPOINT, CPOINT and its affiliate Juno beneficially owned 9,985,175 Common Shares and 8,586,181 Common Share purchase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results